UPMC-Shadyside Hospital is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.
Crixeo Health Trust Score: 87/100 (GOOD). This profile has not yet been claimed by the site owner.
UPMC-Shadyside Hospital has participated in 117 clinical trials with 76 currently active.
Therapeutic areas: Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.
Sponsors: GOG Foundation, National Cancer Institute (NCI), NRG Oncology.
Trust Score: 87/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UPMC-Shadyside Hospital has a Crixeo Trust Score of 87/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UPMC-Shadyside Hospital has 117 clinical trials on record, with 76 currently active. Their work covers Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.
UPMC-Shadyside Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.